However, there were no significant differences of IL-24 concentration among colorectal adenocarcinoma patients with different tumor site (One-way ANOVA, P > 0.05), different differentiation (One-way ANOVA, P > 0.05), or in different TNM stages (One-way ANOVA, P > 0.05). This evidence concerns the gene IL24 and colorectal adenocarcinoma.